CTRI/2026/07/113985进行中（未招募）不适用
A comparative clinical study to evaluate the efficacy of Shalmali Pushpa churna with Madhu and Tandulodak in the management of Sweta Pradar - SPARSH Trial
Dr. Leena0 个研究点目标入组 50 人开始时间: —最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of age between 12 to 60 years
- •Patients with symptoms of Sweta pradar
排除标准
- •Patients with co morbid conditions or severe systemic diseases
- •Patients with other chronic disorders like tuberculosis malignancy diabetes etc
研究者
相似试验
进行中（未招募）
3 期
NN9838-7910: A research study to look at how two different doses of CagriSema and one dose of semaglutide help people living with obesity with or without type 2 diabetes lose weightNutritional, Metabolic, EndocrinePACTR202607641626021Novo Nordisk120
进行中（未招募）
Unknown
Effectiveness of OjasNoor Renewal Serum for BrighteningCTRI/2026/07/114186VedaLume Private Limited, OjasNoor36
进行中（未招募）
2/3 期
A study to compare the effectiveness of two ayurveda treatment approaches each including nasya, lepa and oral medication for improving symptoms in people with frozen shoulderCTRI/2026/07/114183DR AISHWARYA40
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205